Antipodean Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$46.8M |
| 2 |
ENDP
Endo International plc
ENDP
|
+$45.6M |
| 3 |
Lowe's Companies
LOW
|
+$35.2M |
| 4 |
YHOO
Yahoo Inc
YHOO
|
+$30.7M |
| 5 |
Herbalife
HLF
|
+$26.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carter's
CRI
|
+$51.3M |
| 2 |
H&R Block
HRB
|
+$46.5M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$44.8M |
| 4 |
Universal Health Services
UHS
|
+$42.8M |
| 5 |
Cemex
CX
|
+$39.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 28.16% |
| 2 | Consumer Discretionary | 25.38% |
| 3 | Healthcare | 23.95% |
| 4 | Technology | 10.19% |
| 5 | Consumer Staples | 5.75% |
Similar funds
Antipodean Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Antipodean Advisors held 43 positions worth $958M, up 0.56% from $953M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Antipodean Advisors withdrew a net $73.3M in Q3 2013, closing 15 positions and reducing 5 holdings. Its most notable exit was Carter's, an estimated $51.3M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 28% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Antipodean Advisors opened a new position in Meta Platforms (Facebook) worth $63.2M.
- Antipodean Advisors's largest Q3 2013 buy was Meta Platforms (Facebook): 1,258,000 shares worth $63.2M.
- Antipodean Advisors added most to SiriusXM in Q3 2013, an estimated $20.3M increase.
- Antipodean Advisors's biggest Q3 2013 reduction was H&R Block, cutting an estimated $46.5M.
- Antipodean Advisors fully exited Carter's in Q3 2013, selling an estimated $51.3M.
- Antipodean Advisors's ten largest holdings make up 67% of its $958M portfolio in Q3 2013.
- Antipodean Advisors opened 17 new positions and closed 15 in Q3 2013.
- Antipodean Advisors's portfolio value rose 0.56% quarter-over-quarter to $958M.
Based on Antipodean Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.